<DOC>
	<DOC>NCT00637026</DOC>
	<brief_summary>A pre-surgery study to assess changes that occur in human breast cancer material and normal skin after a short course of treatment with Iressa.</brief_summary>
	<brief_title>Ph II Early BC Pre-Surgical Biologic Study</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Gefitinib</mesh_term>
	<criteria>Invasive breast cancer, Aged 18 years or older, Not more than 28 days from initial diagnosis Pregnant or lactating patients, Prior or current radiotherapy for breast cancer, Known allergy reaction to Iressa</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>Iressa, Gefitinib, Breast Cancer, Surgery</keyword>
</DOC>